These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9717843

  • 21. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor.
    Song LN, Gelmann EP.
    J Biol Chem; 2005 Nov 11; 280(45):37853-67. PubMed ID: 16141201
    [Abstract] [Full Text] [Related]

  • 22. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA, Tan JA, He B, Zhou ZX, Mebarki F, Morel Y, Forest MG, Chatelain P, Ritzén EM, French FS, Wilson EM.
    Mech Ageing Dev; 2004 Nov 11; 125(10-11):683-95. PubMed ID: 15541764
    [Abstract] [Full Text] [Related]

  • 23. Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions.
    Duff J, McEwan IJ.
    Mol Endocrinol; 2005 Dec 11; 19(12):2943-54. PubMed ID: 16081517
    [Abstract] [Full Text] [Related]

  • 24. Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP.
    Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S.
    Biochemistry; 2001 Dec 18; 40(50):15369-77. PubMed ID: 11735420
    [Abstract] [Full Text] [Related]

  • 25. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
    Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B.
    Mol Endocrinol; 1999 Jan 18; 13(1):117-28. PubMed ID: 9892017
    [Abstract] [Full Text] [Related]

  • 26. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.
    Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H.
    EMBO J; 1998 Jan 15; 17(2):507-19. PubMed ID: 9430642
    [Abstract] [Full Text] [Related]

  • 27. The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells.
    Moilanen A, Rouleau N, Ikonen T, Palvimo JJ, Jänne OA.
    FEBS Lett; 1997 Jul 28; 412(2):355-8. PubMed ID: 9256251
    [Abstract] [Full Text] [Related]

  • 28. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M, Tanen MR, Bagchi MK.
    Mol Endocrinol; 1997 Jun 28; 11(6):755-67. PubMed ID: 9171239
    [Abstract] [Full Text] [Related]

  • 29. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
    Askew EB, Minges JT, Hnat AT, Wilson EM.
    Mol Cell Endocrinol; 2012 Jan 30; 348(2):403-10. PubMed ID: 21664945
    [Abstract] [Full Text] [Related]

  • 30. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J, Saatcioglu F, Jänne OA, Palvimo JJ.
    Mol Endocrinol; 2001 Jun 30; 15(6):923-35. PubMed ID: 11376111
    [Abstract] [Full Text] [Related]

  • 31. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
    Wafa LA, Cheng H, Rao MA, Nelson CC, Cox M, Hirst M, Sadowski I, Rennie PS.
    Biochem J; 2003 Oct 15; 375(Pt 2):373-83. PubMed ID: 12864730
    [Abstract] [Full Text] [Related]

  • 32. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.
    Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AA, Miner JN, Diamond MI.
    Proc Natl Acad Sci U S A; 2005 Jul 12; 102(28):9802-7. PubMed ID: 15994236
    [Abstract] [Full Text] [Related]

  • 33. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin.
    Li J, Fu J, Toumazou C, Yoon HG, Wong J.
    Mol Endocrinol; 2006 Apr 12; 20(4):776-85. PubMed ID: 16373397
    [Abstract] [Full Text] [Related]

  • 34. Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain.
    Xu X, Yang W, Wang X, Li Y, Wang Y, Ai C.
    Proteins; 2011 Apr 12; 79(4):1154-71. PubMed ID: 21322031
    [Abstract] [Full Text] [Related]

  • 35. The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1.
    Børud B, Hoang T, Bakke M, Jacob AL, Lund J, Mellgren G.
    Mol Endocrinol; 2002 Apr 12; 16(4):757-73. PubMed ID: 11923473
    [Abstract] [Full Text] [Related]

  • 36. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S, Sampson ER, Lee DK, Kim E, Hsu CL, Chen YL, Chang HC, Altuwaijri S, Huang KE, Chang C.
    J Formos Med Assoc; 2000 Dec 12; 99(12):885-94. PubMed ID: 11155740
    [Abstract] [Full Text] [Related]

  • 37. Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1).
    Fuse H, Kitagawa H, Kato S.
    Mol Endocrinol; 2000 Jun 12; 14(6):889-99. PubMed ID: 10847590
    [Abstract] [Full Text] [Related]

  • 38. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
    Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL.
    Cancer Res; 2006 Nov 01; 66(21):10594-602. PubMed ID: 17079484
    [Abstract] [Full Text] [Related]

  • 39. GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
    Shen HC, Buchanan G, Butler LM, Prescott J, Henderson M, Tilley WD, Coetzee GA.
    Biol Chem; 2005 Jan 01; 386(1):69-74. PubMed ID: 15843149
    [Abstract] [Full Text] [Related]

  • 40. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C.
    J Biol Regul Homeost Agents; 2001 Jan 01; 15(2):123-9. PubMed ID: 11501969
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.